Join experts from across IQVIA as they share the latest advances in Alzheimer’s disease clinical research. From breakthrough biomarkers for early patient identification to leveraging global site networks, our leaders will discuss actionable strategies for optimizing AD clinical trials.

Discover how innovative approaches and operational expertise can help biotech and biopharma sponsors lead therapeutic innovation, accelerate recruitment, overcome trial challenges and stay ahead in a rapidly evolving market.

Key takeaways

• Understand the impacts of biomarkers and diagnostics for earlier, more precise detection.
• Highlight best practices in patient recruitment, site management and global trial execution for operational excellence.
• Learn how novel trial designs and patient identification are transforming early intervention strategies in Alzheimer’s research.

Panel:

Joanna Pulawska, Ph.D., Therapeutic Area Head, CNS, IQVIA Biotech
Marek Bieniek, M.D., Senior Director, Medical Strategy, CNS Center of Excellence, IQVIA
Anu Chaudhary, Ph.D., Director, Global Lead Immunology, IQVIA Laboratories

For more information and to register, click here.